• New Tenofovir Prodrug Is Noninferior to Currently Used Prodrug Antiretroviral (ART) combinations containing the recently approved tenofovir alafenamide prodrug offer similar effectiveness and tolerability to those of combinations containing tenofovir disoproxil fumarate, according to two noninferiority trials.
  • Republicans Join Democratic Call for Clarity on Trump Abortion Order Two of President Donald Trump's fellow Republicans joined four Democrats on Monday in demanding that the White House provide more information about an executive order that has sown confusion among international organizations involved in family planning, AIDS treatment and other healthcare issues.

Today on Medscape

Top Stories from Across Medicine

Top Medical News from Across Medscape

  • Mobile App Ok for Postoperative Follow-upUsing a mobile app for follow-up care after breast reconstruction surgery was both convenient and well-liked by patients and did not compromise recovery relative to in-person care, a study has found.
  • 'Suggestion' of Brain Changes on Statins by fMRI in STOMPDespite few differences at cognitive testing for patients on atorvastatin vs placebo in the STOMP substudy, "small but significant" neuronal changes were seen on statins, their meaning unclear.


Business of Medicine

  • Are You Leaving Tax Money on the Table? Are you still working on your tax returns? Here are some important ways to get all of the deductions you deserve.
  • The State Shouldn't Tell Doctors What to Say, Says Ethicist   Dr Art Caplan, bioethicist, discusses physicians' right to talk to their patients about certain topics, including gun safety and the abortion reversal pill, in view of various state legislation.


Advisory Board


Site Editorial Director

Medscape Editor-in-Chief

  • Eric J. Topol, MD Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute; Senior Consultant, Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California; Editor-in-Chief, Medscape